This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Laurence Morellato: Innovator in Peptide Research
Introduction
Laurence Morellato is a notable inventor based in Cachan, France. She has made significant contributions to the field of peptide research, particularly in the development of therapeutic applications for HIV.
Latest Patents
Morellato holds a patent for "CD4 mimic peptides and their uses." This patent describes an isolated peptide comprising a specific sequence that includes thiopropionic acid and various amino acids. The patent outlines the use of this peptide in manufacturing anti-HIV therapeutic or vaccine compositions, showcasing her innovative approach to addressing critical health challenges.
Career Highlights
Throughout her career, Laurence Morellato has worked with prestigious organizations, including the Commissariat à l'Énergie Atomique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. Her work in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Morellato has collaborated with notable colleagues, including Claudio Vita and Loïc Martin. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.
Conclusion
Laurence Morellato's contributions to peptide research and her innovative patent for anti-HIV applications highlight her role as a leading inventor in her field. Her work continues to inspire advancements in therapeutic solutions.